Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis : Noradrenergic hyperactivity with contribution from dopaminergic hyperactivity

The significance of increased sensitivity to stress associated with noradrenergic hyperactivity involving dopaminergic change in spontaneous recurrences of methamphetamine (MAP) psychosis (flashbacks) was examined. Plasma monoamine metabolite levels were assayed in 18 subjects with flashbacks who ha...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical psychopharmacology 2000-04, Vol.20 (2), p.165-174
Hauptverfasser: YUI, K, GOTO, K, IKEMOTO, S, ISHIGURO, T, KAMATA, Y
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 174
container_issue 2
container_start_page 165
container_title Journal of clinical psychopharmacology
container_volume 20
creator YUI, K
GOTO, K
IKEMOTO, S
ISHIGURO, T
KAMATA, Y
description The significance of increased sensitivity to stress associated with noradrenergic hyperactivity involving dopaminergic change in spontaneous recurrences of methamphetamine (MAP) psychosis (flashbacks) was examined. Plasma monoamine metabolite levels were assayed in 18 subjects with flashbacks who had been exposed to stressful events plus MAP-induced frightening psychotic symptoms (N = 11) or frightening psychotic symptoms alone (N = 7) during previous MAP use, in 15 nonflashbackers with a history of MAP psychosis, in 8 subjects with persistent MAP psychosis, and in 27 control subjects. Monoaminergic values were subjected to a square-root transformation, rendering the distribution normal. The numbers of stressful events (mostly threatening events) and frightening psychotic symptoms were significantly higher in the flashbackers than in the nonflashbackers. Factors triggering flashbacks were mild psychosocial stressors (mostly a mild fear of other people). During flashbacks, plasma norepinephrine levels increased, and the flashbackers, 11 of whom had experienced stressful events plus frightening psychotic symptoms, had an additional small increase in plasma levels of 3-methoxytyramine, which is indicative of dopamine release. Thus, threatening stressful events, together with MAP use, may induce noradrenergic hyperreactivity to subsequent mild stressors. Threatening, stressful events plus frightening psychotic symptoms may further induce increased dopamine release in response to mild stressors. Increased sensitivity to stress associated with noradrenergic hyperactivity involving increased dopamine release may have elicited memories of MAP psychosis related to frightening, stressful experiences. The increased sensitivity may be critical for the development of flashbacks.
doi_str_mv 10.1097/00004714-200004000-00008
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00004714_200004000_00008</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10770454</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-bb6078360e62cfe5812f5ada883b4a71e07d81bb6345c279b24911ac4ba4a4e73</originalsourceid><addsrcrecordid>eNplkN1K5EAQhRtZ0Vn1FaQvvI32X6Yz3omsPyDrjYJ3odKpmF5Md-jqUeaFfE7jzOy6YEFRh-I75-IwxqU4lWJhz8Q0xkpTqLWatvgU1Q6byVLrwkr19IPNhLKyENYs9tlPoj9CSGNVucf2pbBWmNLM2PttcAmBsOWEgXz2rz6veI6cckIi7gOnMYYMAeOSeEK3TAmDQx47PmDuYRh7zDD4gHyklesjeeLn_HdM0E4kpmfveL8aMYHbxr_53HM3pSbfLLOPgXcpDryN4zrnu-OQ7XbwQni0vQfs8erXw-VNcXd_fXt5cVc4bWUummYubKXnAufKdVhWUnUltFBVujFgJQrbVnKitCmdsotGmYWU4EwDBgxafcCqTa5LkShhV4_JD5BWtRT1Z_X13-rrf9WvX9VkPd5Yx2UzYPufcdP1BJxsASAHL12C4Dx9cdrMS6n0B0wakh8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis : Noradrenergic hyperactivity with contribution from dopaminergic hyperactivity</title><source>Journals@Ovid Complete - AutoHoldings</source><source>MEDLINE</source><creator>YUI, K ; GOTO, K ; IKEMOTO, S ; ISHIGURO, T ; KAMATA, Y</creator><creatorcontrib>YUI, K ; GOTO, K ; IKEMOTO, S ; ISHIGURO, T ; KAMATA, Y</creatorcontrib><description>The significance of increased sensitivity to stress associated with noradrenergic hyperactivity involving dopaminergic change in spontaneous recurrences of methamphetamine (MAP) psychosis (flashbacks) was examined. Plasma monoamine metabolite levels were assayed in 18 subjects with flashbacks who had been exposed to stressful events plus MAP-induced frightening psychotic symptoms (N = 11) or frightening psychotic symptoms alone (N = 7) during previous MAP use, in 15 nonflashbackers with a history of MAP psychosis, in 8 subjects with persistent MAP psychosis, and in 27 control subjects. Monoaminergic values were subjected to a square-root transformation, rendering the distribution normal. The numbers of stressful events (mostly threatening events) and frightening psychotic symptoms were significantly higher in the flashbackers than in the nonflashbackers. Factors triggering flashbacks were mild psychosocial stressors (mostly a mild fear of other people). During flashbacks, plasma norepinephrine levels increased, and the flashbackers, 11 of whom had experienced stressful events plus frightening psychotic symptoms, had an additional small increase in plasma levels of 3-methoxytyramine, which is indicative of dopamine release. Thus, threatening stressful events, together with MAP use, may induce noradrenergic hyperreactivity to subsequent mild stressors. Threatening, stressful events plus frightening psychotic symptoms may further induce increased dopamine release in response to mild stressors. Increased sensitivity to stress associated with noradrenergic hyperactivity involving increased dopamine release may have elicited memories of MAP psychosis related to frightening, stressful experiences. The increased sensitivity may be critical for the development of flashbacks.</description><identifier>ISSN: 0271-0749</identifier><identifier>EISSN: 1533-712X</identifier><identifier>DOI: 10.1097/00004714-200004000-00008</identifier><identifier>PMID: 10770454</identifier><identifier>CODEN: JCPYDR</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Arousal - drug effects ; Arousal - physiology ; Biological and medical sciences ; Brain - drug effects ; Brain - physiopathology ; Central Nervous System Stimulants - adverse effects ; Dopamine - physiology ; Drug toxicity and drugs side effects treatment ; Female ; Humans ; Life Change Events ; Medical sciences ; Mental Recall - drug effects ; Mental Recall - physiology ; Methamphetamine - adverse effects ; Norepinephrine - physiology ; Pharmacology. Drug treatments ; Prisoners - psychology ; Psychoses, Substance-Induced - physiopathology ; Psychoses, Substance-Induced - psychology ; Recurrence ; Stress, Psychological - complications ; Stress, Psychological - physiopathology ; Toxicity: nervous system and muscle</subject><ispartof>Journal of clinical psychopharmacology, 2000-04, Vol.20 (2), p.165-174</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-bb6078360e62cfe5812f5ada883b4a71e07d81bb6345c279b24911ac4ba4a4e73</citedby><cites>FETCH-LOGICAL-c371t-bb6078360e62cfe5812f5ada883b4a71e07d81bb6345c279b24911ac4ba4a4e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1346512$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10770454$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>YUI, K</creatorcontrib><creatorcontrib>GOTO, K</creatorcontrib><creatorcontrib>IKEMOTO, S</creatorcontrib><creatorcontrib>ISHIGURO, T</creatorcontrib><creatorcontrib>KAMATA, Y</creatorcontrib><title>Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis : Noradrenergic hyperactivity with contribution from dopaminergic hyperactivity</title><title>Journal of clinical psychopharmacology</title><addtitle>J Clin Psychopharmacol</addtitle><description>The significance of increased sensitivity to stress associated with noradrenergic hyperactivity involving dopaminergic change in spontaneous recurrences of methamphetamine (MAP) psychosis (flashbacks) was examined. Plasma monoamine metabolite levels were assayed in 18 subjects with flashbacks who had been exposed to stressful events plus MAP-induced frightening psychotic symptoms (N = 11) or frightening psychotic symptoms alone (N = 7) during previous MAP use, in 15 nonflashbackers with a history of MAP psychosis, in 8 subjects with persistent MAP psychosis, and in 27 control subjects. Monoaminergic values were subjected to a square-root transformation, rendering the distribution normal. The numbers of stressful events (mostly threatening events) and frightening psychotic symptoms were significantly higher in the flashbackers than in the nonflashbackers. Factors triggering flashbacks were mild psychosocial stressors (mostly a mild fear of other people). During flashbacks, plasma norepinephrine levels increased, and the flashbackers, 11 of whom had experienced stressful events plus frightening psychotic symptoms, had an additional small increase in plasma levels of 3-methoxytyramine, which is indicative of dopamine release. Thus, threatening stressful events, together with MAP use, may induce noradrenergic hyperreactivity to subsequent mild stressors. Threatening, stressful events plus frightening psychotic symptoms may further induce increased dopamine release in response to mild stressors. Increased sensitivity to stress associated with noradrenergic hyperactivity involving increased dopamine release may have elicited memories of MAP psychosis related to frightening, stressful experiences. The increased sensitivity may be critical for the development of flashbacks.</description><subject>Adult</subject><subject>Arousal - drug effects</subject><subject>Arousal - physiology</subject><subject>Biological and medical sciences</subject><subject>Brain - drug effects</subject><subject>Brain - physiopathology</subject><subject>Central Nervous System Stimulants - adverse effects</subject><subject>Dopamine - physiology</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Female</subject><subject>Humans</subject><subject>Life Change Events</subject><subject>Medical sciences</subject><subject>Mental Recall - drug effects</subject><subject>Mental Recall - physiology</subject><subject>Methamphetamine - adverse effects</subject><subject>Norepinephrine - physiology</subject><subject>Pharmacology. Drug treatments</subject><subject>Prisoners - psychology</subject><subject>Psychoses, Substance-Induced - physiopathology</subject><subject>Psychoses, Substance-Induced - psychology</subject><subject>Recurrence</subject><subject>Stress, Psychological - complications</subject><subject>Stress, Psychological - physiopathology</subject><subject>Toxicity: nervous system and muscle</subject><issn>0271-0749</issn><issn>1533-712X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkN1K5EAQhRtZ0Vn1FaQvvI32X6Yz3omsPyDrjYJ3odKpmF5Md-jqUeaFfE7jzOy6YEFRh-I75-IwxqU4lWJhz8Q0xkpTqLWatvgU1Q6byVLrwkr19IPNhLKyENYs9tlPoj9CSGNVucf2pbBWmNLM2PttcAmBsOWEgXz2rz6veI6cckIi7gOnMYYMAeOSeEK3TAmDQx47PmDuYRh7zDD4gHyklesjeeLn_HdM0E4kpmfveL8aMYHbxr_53HM3pSbfLLOPgXcpDryN4zrnu-OQ7XbwQni0vQfs8erXw-VNcXd_fXt5cVc4bWUummYubKXnAufKdVhWUnUltFBVujFgJQrbVnKitCmdsotGmYWU4EwDBgxafcCqTa5LkShhV4_JD5BWtRT1Z_X13-rrf9WvX9VkPd5Yx2UzYPufcdP1BJxsASAHL12C4Dx9cdrMS6n0B0wakh8</recordid><startdate>20000401</startdate><enddate>20000401</enddate><creator>YUI, K</creator><creator>GOTO, K</creator><creator>IKEMOTO, S</creator><creator>ISHIGURO, T</creator><creator>KAMATA, Y</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20000401</creationdate><title>Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis : Noradrenergic hyperactivity with contribution from dopaminergic hyperactivity</title><author>YUI, K ; GOTO, K ; IKEMOTO, S ; ISHIGURO, T ; KAMATA, Y</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-bb6078360e62cfe5812f5ada883b4a71e07d81bb6345c279b24911ac4ba4a4e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adult</topic><topic>Arousal - drug effects</topic><topic>Arousal - physiology</topic><topic>Biological and medical sciences</topic><topic>Brain - drug effects</topic><topic>Brain - physiopathology</topic><topic>Central Nervous System Stimulants - adverse effects</topic><topic>Dopamine - physiology</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Female</topic><topic>Humans</topic><topic>Life Change Events</topic><topic>Medical sciences</topic><topic>Mental Recall - drug effects</topic><topic>Mental Recall - physiology</topic><topic>Methamphetamine - adverse effects</topic><topic>Norepinephrine - physiology</topic><topic>Pharmacology. Drug treatments</topic><topic>Prisoners - psychology</topic><topic>Psychoses, Substance-Induced - physiopathology</topic><topic>Psychoses, Substance-Induced - psychology</topic><topic>Recurrence</topic><topic>Stress, Psychological - complications</topic><topic>Stress, Psychological - physiopathology</topic><topic>Toxicity: nervous system and muscle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>YUI, K</creatorcontrib><creatorcontrib>GOTO, K</creatorcontrib><creatorcontrib>IKEMOTO, S</creatorcontrib><creatorcontrib>ISHIGURO, T</creatorcontrib><creatorcontrib>KAMATA, Y</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of clinical psychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>YUI, K</au><au>GOTO, K</au><au>IKEMOTO, S</au><au>ISHIGURO, T</au><au>KAMATA, Y</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis : Noradrenergic hyperactivity with contribution from dopaminergic hyperactivity</atitle><jtitle>Journal of clinical psychopharmacology</jtitle><addtitle>J Clin Psychopharmacol</addtitle><date>2000-04-01</date><risdate>2000</risdate><volume>20</volume><issue>2</issue><spage>165</spage><epage>174</epage><pages>165-174</pages><issn>0271-0749</issn><eissn>1533-712X</eissn><coden>JCPYDR</coden><abstract>The significance of increased sensitivity to stress associated with noradrenergic hyperactivity involving dopaminergic change in spontaneous recurrences of methamphetamine (MAP) psychosis (flashbacks) was examined. Plasma monoamine metabolite levels were assayed in 18 subjects with flashbacks who had been exposed to stressful events plus MAP-induced frightening psychotic symptoms (N = 11) or frightening psychotic symptoms alone (N = 7) during previous MAP use, in 15 nonflashbackers with a history of MAP psychosis, in 8 subjects with persistent MAP psychosis, and in 27 control subjects. Monoaminergic values were subjected to a square-root transformation, rendering the distribution normal. The numbers of stressful events (mostly threatening events) and frightening psychotic symptoms were significantly higher in the flashbackers than in the nonflashbackers. Factors triggering flashbacks were mild psychosocial stressors (mostly a mild fear of other people). During flashbacks, plasma norepinephrine levels increased, and the flashbackers, 11 of whom had experienced stressful events plus frightening psychotic symptoms, had an additional small increase in plasma levels of 3-methoxytyramine, which is indicative of dopamine release. Thus, threatening stressful events, together with MAP use, may induce noradrenergic hyperreactivity to subsequent mild stressors. Threatening, stressful events plus frightening psychotic symptoms may further induce increased dopamine release in response to mild stressors. Increased sensitivity to stress associated with noradrenergic hyperactivity involving increased dopamine release may have elicited memories of MAP psychosis related to frightening, stressful experiences. The increased sensitivity may be critical for the development of flashbacks.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>10770454</pmid><doi>10.1097/00004714-200004000-00008</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0271-0749
ispartof Journal of clinical psychopharmacology, 2000-04, Vol.20 (2), p.165-174
issn 0271-0749
1533-712X
language eng
recordid cdi_crossref_primary_10_1097_00004714_200004000_00008
source Journals@Ovid Complete - AutoHoldings; MEDLINE
subjects Adult
Arousal - drug effects
Arousal - physiology
Biological and medical sciences
Brain - drug effects
Brain - physiopathology
Central Nervous System Stimulants - adverse effects
Dopamine - physiology
Drug toxicity and drugs side effects treatment
Female
Humans
Life Change Events
Medical sciences
Mental Recall - drug effects
Mental Recall - physiology
Methamphetamine - adverse effects
Norepinephrine - physiology
Pharmacology. Drug treatments
Prisoners - psychology
Psychoses, Substance-Induced - physiopathology
Psychoses, Substance-Induced - psychology
Recurrence
Stress, Psychological - complications
Stress, Psychological - physiopathology
Toxicity: nervous system and muscle
title Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis : Noradrenergic hyperactivity with contribution from dopaminergic hyperactivity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T01%3A23%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increased%20sensitivity%20to%20stress%20in%20spontaneous%20recurrence%20of%20methamphetamine%20psychosis%20:%20Noradrenergic%20hyperactivity%20with%20contribution%20from%20dopaminergic%20hyperactivity&rft.jtitle=Journal%20of%20clinical%20psychopharmacology&rft.au=YUI,%20K&rft.date=2000-04-01&rft.volume=20&rft.issue=2&rft.spage=165&rft.epage=174&rft.pages=165-174&rft.issn=0271-0749&rft.eissn=1533-712X&rft.coden=JCPYDR&rft_id=info:doi/10.1097/00004714-200004000-00008&rft_dat=%3Cpubmed_cross%3E10770454%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/10770454&rfr_iscdi=true